EphB4 monomer inhibits chronic graft vasculopathy in an aortic transplant model

John T. Langford, Luis Gonzalez, Ryosuke Taniguchi, Anand Brahmandam, Weichang Zhang, Alan Dardik*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

Abstract

T cells and macrophages play an important role in the formation of allograft vasculopathy, which is the predominant form of chronic rejection in cardiac transplants. Arteries express Ephrin-B2 as a marker of arterial identity, whereas circulating monocytes express the cognate receptor EphB4, which facilitates monocyte adhesion to the endothelial surface. Adherent monocytes transmigrate and differentiate into macrophages that activate T cells and are a main source of tissue damage during rejection. We hypothesized that inhibition of Ephrin-B2-EphB4 binding would decrease immune cell accumulation within a transplanted graft and prevent allograft vasculopathy. We used EphB4 monomer to inhibit Ephrin-B2-EphB4 binding in a rat infrarenal aortic transplant model. Rats treated with EphB4 monomer had fewer macrophages and T cells in the aortic allografts at 28 days, as well as significantly less neointima formation. These data show that the Ephin-B2-EphB4 axis may be an important target for prevention or treatment of allograft vasculopathy.

Original languageEnglish (US)
Article number100109
JournalJVS-Vascular Science
Volume4
DOIs
StatePublished - Jan 2023

Keywords

  • Allograft
  • Allograft vasculopathy
  • Eph-B4
  • Ephrin-B2
  • Neointimal hyperplasia

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Fingerprint

Dive into the research topics of 'EphB4 monomer inhibits chronic graft vasculopathy in an aortic transplant model'. Together they form a unique fingerprint.

Cite this